Trulicity

Trulicity Injection – Uses, Weight Loss Effects, Side Effects, and Cost

Trulicity® (dulaglutide) is an FDA-approved once-weekly GLP-1 injection used with diet and exercise to improve blood sugar control in adults and children ages 10+ with type 2 diabetes. Trulicity is also FDA approved to reduce the risk of major cardiovascular events, including heart attack, stroke, and cardiovascular death, in adults with type 2 diabetes and existing heart disease or multiple risk factors.

How Trulicity Works

Trulicity is a GLP-1 receptor agonist that helps:

Stimulate insulin release

Reduce liver glucose production

Slow digestion and gastric emptying

Improve appetite control and fullness

Weight Loss Effects

Although not FDA approved for weight loss, Trulicity may cause clinically meaningful weight loss as a secondary effect. Some healthcare providers prescribe Trulicity off-label for weight management, with studies showing higher doses are associated with greater weight reduction.

Dosage & Administration

Trulicity is administered as a once-weekly injection using a single-dose pen. Adult dosing ranges from 0.75 mg to 4.5 mg weekly, depending on response and tolerance.

Side Effects & Safety

Common side effects include nausea, diarrhea, vomiting, and abdominal pain, particularly during dose escalation. Trulicity carries an FDA boxed warning for thyroid C-cell tumors (seen in animal studies) and should not be used by patients with medullary thyroid carcinoma (MTC) or MEN 2. Rare but serious risks include pancreatitis, severe allergic reactions, kidney injury, and gallbladder disease.

Cost & Availability

The list price of Trulicity is approximately $886 per month without insurance. Patients frequently search for insurance coverage, manufacturer savings programs, and updates on GLP-1 drug shortages, which have impacted availability nationwide due to increased demand.

Weight Loss Injections provides access to GLP-1 medications through licensed U.S. providers, offering online consultations and nationwide delivery for eligible patients.